Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma-Reference-Cited by-同舟云学术

Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma

Published:2014-12-19 Issue:1 Volume:22 Page:44-54
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Lathrop M J,Sage E K,Macura S L,Brooks E M,Cruz F,Bonenfant N R,Sokocevic D,MacPherson M B,Beuschel S L,Dunaway C W,Shukla A,Janes S M,Steele C,Mossman B T,Weiss D J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt201468.pdf

Reference51 articles.

1. Heintz NH, Janssen-Heininger YM, Mossman BT . Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. Am J Respir Cell Mol Biol 2010; 42: 133–139.

2. Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Beuschel SL, Butnor KJ et al. Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Ann NY Acad Sci 2010; 1203: 7–14.

3. Izzi V, Masuelli L, Tresoldi I, Foti C, Modesti A, Bei R . Immunity and malignant mesothelioma: from mesothelial cell damage to tumor development and immune response-based therapies. Cancer Lett 2012; 322: 18–34.

4. Linton A, van Zandwijk N, Reid G, Clarke S, Cao C, Kao S . Inflammation in malignant mesothelioma—friend or foe? Ann Cardiothorac Surg 2012; 1: 516–522.

5. Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT . Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 2003; 34: 1117–1129.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Cancer Treatment: Harnessing the Power of Mesenchymal Stem Cells for Precise Targeted Therapy in the Tumor Microenvironment;Current Topics in Medicinal Chemistry;2024-05-23

2. Biological differences between adult and perinatal human mesenchymal stromal cells and their impact on the manufacturing processes;Cytotherapy;2024-05

3. New insights in application of mesenchymal stem cells therapy in tumor microenvironment: pros and cons;Frontiers in Cell and Developmental Biology;2023-10-02

4. Scalable manufacturing of gene-modified human mesenchymal stromal cells with microcarriers in spinner flasks;Applied Microbiology and Biotechnology;2023-07-20

5. Genetically-modified Stem Cell in Regenerative Medicine and Cancer Therapy; A New Era;Current Gene Therapy;2022-02